31 related articles for article (PubMed ID: 20036471)
1. ID4 regulates mammary gland development by suppressing p38MAPK activity.
Dong J; Huang S; Caikovski M; Ji S; McGrath A; Custorio MG; Creighton CJ; Maliakkal P; Bogoslovskaia E; Du Z; Zhang X; Lewis MT; Sablitzky F; Brisken C; Li Y
Development; 2011 Dec; 138(23):5247-56. PubMed ID: 22069192
[TBL] [Abstract][Full Text] [Related]
2. Kaempferol, a Phytoprogestin, Induces a Subset of Progesterone-Regulated Genes in the Uterus.
Bergsten TM; Li K; Lantvit DD; Murphy BT; Burdette JE
Nutrients; 2023 Mar; 15(6):. PubMed ID: 36986136
[TBL] [Abstract][Full Text] [Related]
3. Co-administering Melatonin With an Estradiol-Progesterone Menopausal Hormone Therapy Represses Mammary Cancer Development in a Mouse Model of HER2-Positive Breast Cancer.
Dodda BR; Bondi CD; Hasan M; Clafshenkel WP; Gallagher KM; Kotlarczyk MP; Sethi S; Buszko E; Latimer JJ; Cline JM; Witt-Enderby PA; Davis VL
Front Oncol; 2019; 9():525. PubMed ID: 31355130
[TBL] [Abstract][Full Text] [Related]
4. Progesterone in Peri- and Postmenopause: A Review.
Regidor PA
Geburtshilfe Frauenheilkd; 2014 Nov; 74(11):995-1002. PubMed ID: 25484373
[TBL] [Abstract][Full Text] [Related]
5. Suitability of the beagle dog as a test model for the tumorigenic potential of contraceptive steroids. "A short review".
El Etreby MF; Gräf KJ; Beier S; Elger W; Günzel P; Neumann F
Contraception; 1979 Sep; 20(3):237-56. PubMed ID: 389546
[No Abstract] [Full Text] [Related]
6. Comparative analysis of the uterine and mammary gland effects of drospirenone and medroxyprogesterone acetate.
Otto C; Fuchs I; Altmann H; Klewer M; Walter A; Prelle K; Vonk R; Fritzemeier KH
Endocrinology; 2008 Aug; 149(8):3952-9. PubMed ID: 18420741
[TBL] [Abstract][Full Text] [Related]
7. Activity of three selective estrogen receptor modulators on hormone-dependent responses in the mouse uterus and mammary gland.
Crabtree JS; Peano BJ; Zhang X; Komm BS; Winneker RC; Harris HA
Mol Cell Endocrinol; 2008 Jun; 287(1-2):40-6. PubMed ID: 18367319
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the proliferative effects of estradiol and conjugated equine estrogens on human breast cancer cells and impact of continuous combined progestogen addition.
Mueck AO; Seeger H; Wallwiener D
Climacteric; 2003 Sep; 6(3):221-7. PubMed ID: 14567770
[TBL] [Abstract][Full Text] [Related]
9. Effect of progestin treatment on estradiol-and growth factor-stimulated breast cancer cell lines.
Cappelletti V; Miodini P; Fioravanti L; Di Fronzo G
Anticancer Res; 1995; 15(6B):2551-5. PubMed ID: 8669822
[TBL] [Abstract][Full Text] [Related]
10. Mouse bioassay for in vivo screening of oestrogen and progesterone antagonists.
Skarda J; Köhlerová E
J Vet Med A Physiol Pathol Clin Med; 2006 Apr; 53(3):145-53. PubMed ID: 16533331
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of the uterine and mammary gland effects of progesterone and medroxyprogesterone acetate.
Otto C; Fuchs I; Vonk R; Fritzemeier KH
Maturitas; 2010 Apr; 65(4):386-91. PubMed ID: 20036471
[TBL] [Abstract][Full Text] [Related]
12. In vivo characterization of progestins with reduced non-genomic activity in vitro.
Otto C; Rohde-Schulz B; Schwarz G; Fuchs I; Klewer M; Altmann H; Fritzemeier KH
Ernst Schering Found Symp Proc; 2007; (1):151-70. PubMed ID: 18540572
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
